FCS Press Releases

Florida Cancer Specialists & Research Institute (FCS) today held a ribbon-cutting ceremony to mark the opening of its new state-of-the-art cancer center in Manatee County.

Florida Healthcare Specialists (FHS), a division practice of Florida Cancer Specialists & Research Institute (FCS) located in Vero Beach, is proud to announce that urologist Hugo Davila, MD has been designated as the only Center of Excellence Physician in Indian River, St. Lucie and Martin Counties to offer Rezūm™ Water Vapor Therapy treatment.

Jessica Stine, MD, gynecologic oncologist with Florida Cancer Specialists & Research Institute (FCS), and an advanced robotic surgeon who performs the highest volume of GYN robotic surgery in the Tampa Bay area, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical. 

Florida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art Trinity Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders. 

Tampa General Hospital (TGH), the Florida Cancer Specialists & Research Institute (FCS), Proton Therapy Partners and Florida Urology Partners today announced a new collaborative partnership with plans to build a proton therapy center in Tampa Bay that would offer patients across the West Coast of Florida access to an advanced alternative to conventional radiation treatment for cancer and within the convenience of their own backyard.

FCS received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons. 

Three medical oncologists at FCS are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.

Florida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art North Port Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders. Located at 1390 Grand Venture Drive, North Port, FL. 34286, it replaces the FCS clinic at 3085 Bobcat Village Center Road in North Port.

Florida Cancer Specialists & Research Institute (FCS) recently expanded its molecular testing capabilities at its state-of-the-art Pathology Laboratory in Fort Myers and is providing patients with clinical next-generation sequencing (NGS) that are offered at FCS clinics throughout Florida. NGS testing is available for testing of solid tumors and hematologic malignancies and lymph nodes.

Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD will assume the role of President & Managing Physician, effective January 1, 2022. He succeeds Lucio Gordan, MD, who has served in that position since 2018. Dr. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as Chief Medical Officer of Therapeutics and Analytics for the statewide practice.

Senior leaders of Florida Cancer Specialists & Research Institute (FCS) have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.

FCS clinical oncology nutritionist Rhone M. Levin, M.Ed, RDN, CSO, LDN, FAND, is the author of the nutrition chapter featured in the recently published 5th Edition of Lung Cancer Choices.

Sarah Cannon recently opened its newest drug development unit in collaboration with FCS and The University of Central Florida College of Medicine in Lake Nona, Fla.

Four FCS physicians are the authors of five cancer research studies that will be presented at European Society of Medical Oncology 2021.

A panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.

FCS continues to expand the number and scope of clinical trial opportunities available to cancer patients in the community setting.